Difference between revisions of "ICRP Glossary"
(→C) |
|||
(48 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
+ | [[File:Glossary Header-left2.png|800px|frameless|left|link=ICRP Glossary]] | ||
− | + | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. It is a living document, updated regularly. Each entry shows the date it was last updated, and some include past glossary entries to help readers better understand the term in a particular context. | ||
+ | |||
+ | Many ICRP publications have included their own glossaries. The ICRP Glossary includes most of the terms in these other glossaries, many with updated entries. ICRP publications will continue to have their own glossaries when necessary, for example for highly specialized terms relevant to a single publication or helpful for a reader to have close at hand, or when introducing a new term which would also be added to the ICRP Glossary. | ||
+ | |||
+ | Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications. | ||
+ | |||
+ | The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being prepared, and will be added here in due course. | ||
+ | |||
+ | ---- | ||
{| class="wikitable" | {| class="wikitable" | ||
|- | |- | ||
| [[#A|A]] || [[#B|B]] || [[#C|C]]|| [[#D|D]] || [[#E|E]] || [[#F|F]] || [[#G|G]] || [[#H|H]] || [[#I|I]] || [[#J|J]] || [[#K|K]] || [[#L|L]] || [[#M|M]] ||[[#N|N]] || [[#O|O]] || [[#P|P]] || [[#Q|Q]] || [[#R|R]] || [[#S|S]] || [[#T|T]] || [[#U|U]] || [[#V|V]] || [[#W|W]] || [[#X|X]] || [[#Y|Y]] || [[#Z|Z]] | | [[#A|A]] || [[#B|B]] || [[#C|C]]|| [[#D|D]] || [[#E|E]] || [[#F|F]] || [[#G|G]] || [[#H|H]] || [[#I|I]] || [[#J|J]] || [[#K|K]] || [[#L|L]] || [[#M|M]] ||[[#N|N]] || [[#O|O]] || [[#P|P]] || [[#Q|Q]] || [[#R|R]] || [[#S|S]] || [[#T|T]] || [[#U|U]] || [[#V|V]] || [[#W|W]] || [[#X|X]] || [[#Y|Y]] || [[#Z|Z]] | ||
|} | |} | ||
− | + | ||
− | |||
<div style="column-count:2;-moz-column-count:2;-webkit-column-count:2"> | <div style="column-count:2;-moz-column-count:2;-webkit-column-count:2"> | ||
Line 117: | Line 132: | ||
*[[Cardioverter-defibrillator]] | *[[Cardioverter-defibrillator]] | ||
− | |||
− | |||
*[[Cell death]] | *[[Cell death]] | ||
Line 147: | Line 160: | ||
*[[Computed tomography dose index]] | *[[Computed tomography dose index]] | ||
− | |||
− | |||
*[[Connective tissue]] | *[[Connective tissue]] | ||
Line 177: | Line 188: | ||
*[[Decontamination factor]] | *[[Decontamination factor]] | ||
− | |||
− | |||
*[[Deontological Ethics]] | *[[Deontological Ethics]] | ||
Line 213: | Line 222: | ||
*[[Dose rate effectiveness factor]] | *[[Dose rate effectiveness factor]] | ||
− | |||
− | |||
*[[Dose-rate effect]] | *[[Dose-rate effect]] | ||
Line 221: | Line 228: | ||
*[[Dose-threshold]] | *[[Dose-threshold]] | ||
− | |||
− | |||
− | |||
− | |||
=== <big><span id="E">E</span></big> === | === <big><span id="E">E</span></big> === | ||
Line 270: | Line 273: | ||
*[[Ethics]] | *[[Ethics]] | ||
− | *[[Excretion rate]] | + | *[[Excretion rate (instantaneous)]] |
*[[Exempt waste]] | *[[Exempt waste]] | ||
Line 309: | Line 312: | ||
*[[Gamma ray]] | *[[Gamma ray]] | ||
− | |||
− | |||
*[[Gastrointestinal syndrome]] | *[[Gastrointestinal syndrome]] | ||
Line 343: | Line 344: | ||
*[[Hormones]] | *[[Hormones]] | ||
+ | |||
+ | *[[Human respiratory tract model]] | ||
*[[Hyperbaric oxygen]] | *[[Hyperbaric oxygen]] | ||
Line 354: | Line 357: | ||
*[[Immune system]] | *[[Immune system]] | ||
− | *[[In vivo | + | *[[In vivo radiobioassay]] |
*[[Incident]] | *[[Incident]] | ||
Line 362: | Line 365: | ||
*[[Individual decontamination]] | *[[Individual decontamination]] | ||
− | *[[Individual | + | *[[Individual monitoring]] |
− | *[[Individual | + | *[[Individual-related]] |
*[[Informed Consent]] | *[[Informed Consent]] | ||
− | |||
− | |||
*[[Inhalability]] | *[[Inhalability]] | ||
Line 420: | Line 421: | ||
*[[Low level waste]] | *[[Low level waste]] | ||
− | |||
− | |||
*[[Lymphatic system]] | *[[Lymphatic system]] | ||
Line 433: | Line 432: | ||
*[[Medical exposure]] | *[[Medical exposure]] | ||
− | |||
− | |||
*[[Member of the public]] | *[[Member of the public]] | ||
Line 441: | Line 438: | ||
*[[Mitigation]] | *[[Mitigation]] | ||
− | |||
− | |||
*[[Multistage tumorigenesis]] | *[[Multistage tumorigenesis]] | ||
*[[Myocardial perfusion]] | *[[Myocardial perfusion]] | ||
+ | |||
+ | *[[Myocardial stress test]] | ||
=== <big><span id="N">N</span></big> === | === <big><span id="N">N</span></big> === | ||
− | |||
− | |||
− | |||
− | |||
− | |||
*[[Naturally occurring radioactive material]] | *[[Naturally occurring radioactive material]] | ||
Line 473: | Line 465: | ||
*[[Occupational exposure]] | *[[Occupational exposure]] | ||
− | |||
− | |||
*[[Optimisation]] | *[[Optimisation]] | ||
Line 495: | Line 485: | ||
*[[Pericarditis]] | *[[Pericarditis]] | ||
− | |||
− | |||
*[[Pharynx]] | *[[Pharynx]] | ||
Line 507: | Line 495: | ||
*[[Practical radiological protection culture]] | *[[Practical radiological protection culture]] | ||
− | |||
− | |||
− | |||
− | |||
*[[Prevailing circumstances]] | *[[Prevailing circumstances]] | ||
Line 527: | Line 511: | ||
*[[Projected dose]] | *[[Projected dose]] | ||
− | |||
− | |||
*[[Protection strategy]] | *[[Protection strategy]] | ||
Line 535: | Line 517: | ||
*[[Protective action guide]] | *[[Protective action guide]] | ||
− | |||
− | |||
*[[Prudence]] | *[[Prudence]] | ||
Line 548: | Line 528: | ||
=== <big><span id="R">R</span></big> === | === <big><span id="R">R</span></big> === | ||
− | |||
− | |||
*[[Radiation belt]] | *[[Radiation belt]] | ||
Line 576: | Line 554: | ||
*[[Radiological Controlled Area]] | *[[Radiological Controlled Area]] | ||
− | |||
− | |||
*[[Radiological protection principles]] | *[[Radiological protection principles]] | ||
− | |||
− | |||
*[[Radionuclides of natural origin]] | *[[Radionuclides of natural origin]] | ||
Line 596: | Line 570: | ||
*[[Recovery responder]] | *[[Recovery responder]] | ||
− | |||
− | |||
*[[Reference bioassay function]] | *[[Reference bioassay function]] | ||
Line 604: | Line 576: | ||
*[[Reference level]] | *[[Reference level]] | ||
− | |||
− | |||
− | |||
− | |||
*[[Rehabilitation of living conditions]] | *[[Rehabilitation of living conditions]] | ||
Line 638: | Line 606: | ||
*[[Rigidity]] | *[[Rigidity]] | ||
− | |||
− | |||
*[[Routine monitoring]] | *[[Routine monitoring]] | ||
Line 656: | Line 622: | ||
*[[Slow repair]] | *[[Slow repair]] | ||
− | |||
− | |||
*[[Solar cosmic radiation]] | *[[Solar cosmic radiation]] | ||
Line 682: | Line 646: | ||
*[[Storage]] | *[[Storage]] | ||
− | |||
− | |||
− | |||
− | |||
*[[Subcutaneous tissue]] | *[[Subcutaneous tissue]] | ||
Line 692: | Line 652: | ||
*[[Supervised Area]] | *[[Supervised Area]] | ||
− | |||
− | |||
− | |||
− | |||
*[[Systemic model]] | *[[Systemic model]] | ||
Line 703: | Line 659: | ||
*[[Tachycardia]] | *[[Tachycardia]] | ||
− | |||
− | |||
*[[Target region]] | *[[Target region]] | ||
Line 711: | Line 665: | ||
*[[Telangiectasia]] | *[[Telangiectasia]] | ||
− | |||
− | |||
*[[Threshold dose for tissue reactions]] | *[[Threshold dose for tissue reactions]] | ||
Line 723: | Line 675: | ||
*[[Tolerability]] | *[[Tolerability]] | ||
− | |||
− | |||
*[[Track structure]] | *[[Track structure]] | ||
Line 733: | Line 683: | ||
*[[Transforming growth factor]] | *[[Transforming growth factor]] | ||
− | |||
− | |||
*[[Transparency]] | *[[Transparency]] | ||
*[[Trapped particles]] | *[[Trapped particles]] | ||
− | |||
− | |||
*[[Types of materials]] | *[[Types of materials]] |
Revision as of 12:37, 18 November 2020
The ICRP Glossary collects ICRP’s definitive explanations of terms for current use. It is a living document, updated regularly. Each entry shows the date it was last updated, and some include past glossary entries to help readers better understand the term in a particular context.
Many ICRP publications have included their own glossaries. The ICRP Glossary includes most of the terms in these other glossaries, many with updated entries. ICRP publications will continue to have their own glossaries when necessary, for example for highly specialized terms relevant to a single publication or helpful for a reader to have close at hand, or when introducing a new term which would also be added to the ICRP Glossary.
Although the ICRP Glossary is not a dictionary, terms already well covered in the Oxford English Dictionary are not included here unless further explanation is needed to understand the way in which these terms are used in ICRP publications.
The ICRP Glossary shown here comprises some 400 terms. Entries for an additional approximately 400 terms are being prepared, and will be added here in due course.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z |